" class="no-js "lang="en-US"> Industry News Archives - Page 8 of 151 - Medtech Alert
Friday, October 03, 2025

Sort by:

Date

Top Post

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients

ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]

Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases

Ironwood Pharmaceuticals, a GI-focused healthcare company, and VectivBio Holding AG, a clinical-stage biopharmaceutical company pioneering […]

Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms

Stereotaxis today announced a global collaboration with Abbott to integrate Abbott’s EnSite™ X EP System […]

TraceLink Announces Appointment of George Llado, former Merck and Alexion CIO, to Board of Directors

TraceLink, the leading digital network platform company enabling end-to-end product orchestration by connecting more than […]

HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics

Shanghai Stock Exchange-listed company HitGen announced today that it has entered into a research agreement […]

Discovery Life Sciences Joins Akoya Biosciences' Global Service Provider Network to Accelerate Immuno-oncology Research

Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, have announced that it has officially […]

Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer

Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for […]

FzioMed Announces Addition of Industry Veteran to its Board of Directors

FzioMed, a global leading surgical biomaterials company focused on spine, orthopedic, peritoneal and gynecological surgery, […]

Coeptis Therapeutics Appoints Brian Cogley as Chief Financial Officer

Coeptis Therapeutics, a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced today the […]

Prothena Announces Appointment of Billy Dunn, M.D., to its Board of Directors

Prothena, a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on […]

Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors

Ochre Bio, an innovator in chronic liver disease medicine development, today announced the appointment of […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more